Does the media refer more to ALGN or BSX?

In the previous week, Boston Scientific had 31 more articles in the media than Align Technology. MarketBeat recorded 40 mentions for Boston Scientific and 9 mentions for Align Technology. Boston Scientific's average media sentiment score of 1.44 beat Align Technology's score of 0.91 indicating that Boston Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 7 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 36 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor HQY or BSX?

In the previous week, Boston Scientific had 32 more articles in the media than HealthEquity. MarketBeat recorded 40 mentions for Boston Scientific and 8 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.55 beat Boston Scientific's score of 1.44 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Boston Scientific 36 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer BSX or MMSI?

In the previous week, Boston Scientific had 30 more articles in the media than Merit Medical Systems. MarketBeat recorded 40 mentions for Boston Scientific and 10 mentions for Merit Medical Systems. Boston Scientific's average media sentiment score of 1.44 beat Merit Medical Systems' score of 0.92 indicating that Boston Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 36 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor AMN or BSX?

In the previous week, Boston Scientific had 30 more articles in the media than AMN Healthcare Services. MarketBeat recorded 40 mentions for Boston Scientific and 10 mentions for AMN Healthcare Services. Boston Scientific's average media sentiment score of 1.44 beat AMN Healthcare Services' score of 0.82 indicating that Boston Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 36 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, BSX or DVA?

Boston Scientific has higher revenue and earnings than DaVita. DaVita is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Boston Scientific $21.00B 3.48 $2.90B $2.47 20.42 DaVita $13.64B 0.83 $746.80M $12.22 14.44

Is BSX or DVA more profitable?

Boston Scientific has a net margin of 17.50% compared to DaVita's net margin of 6.05%. Boston Scientific's return on equity of 19.28% beat DaVita's return on equity. Company Net Margins Return on Equity Return on Assets Boston Scientific 17.50% 19.28% 10.89% DaVita 6.05% -217.63% 5.07%

Does the media refer more to BSX or DVA?

In the previous week, Boston Scientific had 39 more articles in the media than DaVita. MarketBeat recorded 40 mentions for Boston Scientific and 1 mentions for DaVita. DaVita's average media sentiment score of 1.47 beat Boston Scientific's score of 1.44 indicating that DaVita is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 36 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DaVita 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Boston Scientific (BSX) Competitors

$50.44 -1.57 (-3.02%)

As of 11:04 AM Eastern

Compare

BSX vs. ALGN, HQY, MMSI, AMN, and DVA

Should you buy Boston Scientific stock or one of its competitors? Boston Scientific's main competitors and comparable companies include Align Technology (ALGN), HealthEquity (HQY), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), and DaVita (DVA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Boston Scientific compare to Align Technology?

Align Technology (NASDAQ:ALGN) and Boston Scientific (NYSE:BSX) are both large-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations.

88.4% of Align Technology shares are owned by institutional investors. Comparatively, 89.1% of Boston Scientific shares are owned by institutional investors. 0.8% of Align Technology shares are owned by company insiders. Comparatively, 0.3% of Boston Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Align Technology has a beta of 1.65, indicating that its stock price is 65% more volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.56, indicating that its stock price is 44% less volatile than the broader market.

In the previous week, Boston Scientific had 31 more articles in the media than Align Technology. MarketBeat recorded 40 mentions for Boston Scientific and 9 mentions for Align Technology. Boston Scientific's average media sentiment score of 1.44 beat Align Technology's score of 0.91 indicating that Boston Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Align Technology	7 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Boston Scientific	36 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Boston Scientific has higher revenue and earnings than Align Technology. Boston Scientific is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$4.03B	2.84	$410.35M	$5.75	27.83
Boston Scientific	$21.00B	3.48	$2.90B	$2.47	20.42

Boston Scientific has a net margin of 17.50% compared to Align Technology's net margin of 9.99%. Boston Scientific's return on equity of 19.28% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	9.99%	15.86%	10.32%
Boston Scientific	17.50%	19.28%	10.89%

Align Technology presently has a consensus target price of $206.36, indicating a potential upside of 28.97%. Boston Scientific has a consensus target price of $71.62, indicating a potential upside of 41.98%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Boston Scientific is more favorable than Align Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67
Boston Scientific	2 Sell rating(s)	5 Hold rating(s)	24 Buy rating(s)	0 Strong Buy rating(s)	2.71

Summary

Boston Scientific beats Align Technology on 12 of the 17 factors compared between the two stocks.

How does Boston Scientific compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Boston Scientific (NYSE:BSX) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 89.1% of Boston Scientific shares are held by institutional investors. 1.6% of HealthEquity shares are held by insiders. Comparatively, 0.3% of Boston Scientific shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Boston Scientific had 32 more articles in the media than HealthEquity. MarketBeat recorded 40 mentions for Boston Scientific and 8 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.55 beat Boston Scientific's score of 1.44 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Boston Scientific	36 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity has a beta of 0.21, suggesting that its share price is 79% less volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.56, suggesting that its share price is 44% less volatile than the broader market.

HealthEquity presently has a consensus target price of $110.93, indicating a potential upside of 4.86%. Boston Scientific has a consensus target price of $71.62, indicating a potential upside of 41.98%. Given Boston Scientific's higher probable upside, analysts clearly believe Boston Scientific is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.77
Boston Scientific	2 Sell rating(s)	5 Hold rating(s)	24 Buy rating(s)	0 Strong Buy rating(s)	2.71

Boston Scientific has a net margin of 17.50% compared to HealthEquity's net margin of 17.25%. Boston Scientific's return on equity of 19.28% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.25%	14.75%	9.22%
Boston Scientific	17.50%	19.28%	10.89%

Boston Scientific has higher revenue and earnings than HealthEquity. Boston Scientific is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	6.73	$215.20M	$2.67	39.62
Boston Scientific	$21.00B	3.48	$2.90B	$2.47	20.42

Summary

Boston Scientific beats HealthEquity on 9 of the 16 factors compared between the two stocks.

How does Boston Scientific compare to Merit Medical Systems?

Boston Scientific (NYSE:BSX) and Merit Medical Systems (NASDAQ:MMSI) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment and risk.

In the previous week, Boston Scientific had 30 more articles in the media than Merit Medical Systems. MarketBeat recorded 40 mentions for Boston Scientific and 10 mentions for Merit Medical Systems. Boston Scientific's average media sentiment score of 1.44 beat Merit Medical Systems' score of 0.92 indicating that Boston Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	36 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Boston Scientific has a beta of 0.56, suggesting that its share price is 44% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.49, suggesting that its share price is 51% less volatile than the broader market.

89.1% of Boston Scientific shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 0.3% of Boston Scientific shares are owned by insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Boston Scientific currently has a consensus target price of $71.62, indicating a potential upside of 41.98%. Merit Medical Systems has a consensus target price of $100.00, indicating a potential upside of 10.19%. Given Boston Scientific's stronger consensus rating and higher probable upside, equities research analysts clearly believe Boston Scientific is more favorable than Merit Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	2 Sell rating(s)	5 Hold rating(s)	24 Buy rating(s)	0 Strong Buy rating(s)	2.71
Merit Medical Systems	0 Sell rating(s)	4 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.67

Boston Scientific has higher revenue and earnings than Merit Medical Systems. Boston Scientific is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$21.00B	3.48	$2.90B	$2.47	20.42
Merit Medical Systems	$1.58B	3.43	$128.49M	$2.42	37.50

Boston Scientific has a net margin of 17.50% compared to Merit Medical Systems' net margin of 9.22%. Boston Scientific's return on equity of 19.28% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.50%	19.28%	10.89%
Merit Medical Systems	9.22%	13.75%	8.10%

Summary

Boston Scientific beats Merit Medical Systems on 13 of the 16 factors compared between the two stocks.

How does Boston Scientific compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Boston Scientific (NYSE:BSX) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, media sentiment, analyst recommendations, valuation, risk and institutional ownership.

AMN Healthcare Services presently has a consensus price target of $31.43, indicating a potential downside of 11.12%. Boston Scientific has a consensus price target of $71.62, indicating a potential upside of 41.98%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Boston Scientific is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
Boston Scientific	2 Sell rating(s)	5 Hold rating(s)	24 Buy rating(s)	0 Strong Buy rating(s)	2.71

Boston Scientific has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.50	-$95.70M	$2.68	13.19
Boston Scientific	$21.00B	3.48	$2.90B	$2.47	20.42

Boston Scientific has a net margin of 17.50% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat Boston Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	3.06%	19.92%	5.93%
Boston Scientific	17.50%	19.28%	10.89%

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 89.1% of Boston Scientific shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by company insiders. Comparatively, 0.3% of Boston Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

AMN Healthcare Services has a beta of 0.4, indicating that its share price is 60% less volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.56, indicating that its share price is 44% less volatile than the broader market.

In the previous week, Boston Scientific had 30 more articles in the media than AMN Healthcare Services. MarketBeat recorded 40 mentions for Boston Scientific and 10 mentions for AMN Healthcare Services. Boston Scientific's average media sentiment score of 1.44 beat AMN Healthcare Services' score of 0.82 indicating that Boston Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Boston Scientific	36 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Boston Scientific beats AMN Healthcare Services on 12 of the 16 factors compared between the two stocks.

How does Boston Scientific compare to DaVita?

Boston Scientific (NYSE:BSX) and DaVita (NYSE:DVA) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends and profitability.

In the previous week, Boston Scientific had 39 more articles in the media than DaVita. MarketBeat recorded 40 mentions for Boston Scientific and 1 mentions for DaVita. DaVita's average media sentiment score of 1.47 beat Boston Scientific's score of 1.44 indicating that DaVita is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	36 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DaVita	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Boston Scientific has higher revenue and earnings than DaVita. DaVita is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$21.00B	3.48	$2.90B	$2.47	20.42
DaVita	$13.64B	0.83	$746.80M	$12.22	14.44

89.1% of Boston Scientific shares are held by institutional investors. Comparatively, 90.1% of DaVita shares are held by institutional investors. 0.3% of Boston Scientific shares are held by company insiders. Comparatively, 1.9% of DaVita shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Boston Scientific has a net margin of 17.50% compared to DaVita's net margin of 6.05%. Boston Scientific's return on equity of 19.28% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.50%	19.28%	10.89%
DaVita	6.05%	-217.63%	5.07%

Boston Scientific has a beta of 0.56, meaning that its share price is 44% less volatile than the broader market. Comparatively, DaVita has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

Boston Scientific presently has a consensus target price of $71.62, suggesting a potential upside of 41.98%. DaVita has a consensus target price of $221.75, suggesting a potential upside of 25.63%. Given Boston Scientific's stronger consensus rating and higher probable upside, research analysts clearly believe Boston Scientific is more favorable than DaVita.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	2 Sell rating(s)	5 Hold rating(s)	24 Buy rating(s)	0 Strong Buy rating(s)	2.71
DaVita	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38

Summary

Boston Scientific beats DaVita on 11 of the 16 factors compared between the two stocks.

Get Boston Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BSX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BSX vs. The Competition

Export

Metric	Boston Scientific	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$73.10B	$5.80B	$7.26B	$24.19B
Dividend Yield	N/A	1.76%	2.55%	3.72%
P/E Ratio	20.42	25.98	269.16	30.11
Price / Sales	3.48	40.97	615.85	19.97
Price / Cash	12.51	33.29	78.23	31.97
Price / Book	2.90	5.97	13.06	6.84
Net Income	$2.90B	$148.28M	$3.46B	$1.07B
7 Day Performance	-2.59%	0.48%	1.37%	-0.98%
1 Month Performance	14.99%	5.66%	4.49%	2.54%
1 Year Performance	-52.37%	9.58%	27.84%	17.82%

Boston Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BSX Boston Scientific	4.9528 of 5 stars	$50.44 -3.0%	$71.62 +42.0%	-49.8%	$73.10B	$21.00B	20.42	59,000	Positive News
ALGN Align Technology	4.6131 of 5 stars	$176.04 +1.4%	$206.36 +17.2%	+13.4%	$12.61B	$4.03B	30.62	20,290
HQY HealthEquity	4.063 of 5 stars	$106.79 +2.1%	$110.93 +3.9%	+15.6%	$8.93B	$1.31B	40.00	2,814	Upcoming Earnings
MMSI Merit Medical Systems	3.3389 of 5 stars	$89.75 +0.8%	$100.30 +11.8%	+5.5%	$5.36B	$1.52B	37.09	7,500	Analyst Upgrade Gap Down
AMN AMN Healthcare Services	2.0792 of 5 stars	$36.40 +1.1%	$30.86 -15.2%	+76.1%	$1.41B	$3.43B	13.58	2,664	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:BSX) was last updated on 8/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Boston Scientific (BSX) Competitors

BSX vs. ALGN, HQY, MMSI, AMN, and DVA

How does Boston Scientific compare to Align Technology?

Summary

How does Boston Scientific compare to HealthEquity?

Summary

How does Boston Scientific compare to Merit Medical Systems?

Summary

How does Boston Scientific compare to AMN Healthcare Services?

Summary

How does Boston Scientific compare to DaVita?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BSX vs. The Competition

Boston Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Boston Scientific (BSX) Competitors

BSX vs. ALGN, HQY, MMSI, AMN, and DVA

How does Boston Scientific compare to Align Technology?

Do insiders & institutionals have more ownership in ALGN or BSX?

Which has more risk and volatility, ALGN or BSX?

Does the media refer more to ALGN or BSX?

Which has higher earnings & valuation, ALGN or BSX?

Is ALGN or BSX more profitable?

Do analysts recommend ALGN or BSX?

Summary

How does Boston Scientific compare to HealthEquity?

Do insiders and institutionals have more ownership in HQY or BSX?

Does the media favor HQY or BSX?

Which has more volatility & risk, HQY or BSX?

Do analysts rate HQY or BSX?

Is HQY or BSX more profitable?

Which has higher earnings and valuation, HQY or BSX?

Summary

How does Boston Scientific compare to Merit Medical Systems?

Does the media prefer BSX or MMSI?

Which has more risk and volatility, BSX or MMSI?

Do institutionals and insiders have more ownership in BSX or MMSI?

Do analysts recommend BSX or MMSI?

Which has better valuation and earnings, BSX or MMSI?

Is BSX or MMSI more profitable?

Summary

How does Boston Scientific compare to AMN Healthcare Services?

Do analysts rate AMN or BSX?

Which has stronger valuation & earnings, AMN or BSX?

Is AMN or BSX more profitable?

Do institutionals & insiders believe in AMN or BSX?

Which has more risk and volatility, AMN or BSX?

Does the media favor AMN or BSX?

Summary

How does Boston Scientific compare to DaVita?

Does the media refer more to BSX or DVA?

Which has preferable earnings and valuation, BSX or DVA?

Do institutionals and insiders believe in BSX or DVA?

Is BSX or DVA more profitable?

Which has more volatility and risk, BSX or DVA?

Do analysts rate BSX or DVA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BSX vs. The Competition

Boston Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools